The Primary
Care Companionfor CNS Disorders

Suicide

Letter to the Editor December 15, 2008

Suicide Attempt and Psychosis Revealed After an Apparent Traffic Accident: A Case Report

Rashmi Ojha, M.D.

Prim Care Companion J Clin Psychiatry 2008;10(6):486-486

Article Abstract

Letter to the Editor

Suicide Attempt and Psychosis Revealed After an Apparent Traffic Accident: A Case Report

About the Authors

Rashmi Ojha, M.D.

View full profile

Download Free PDF

This PDF is free for all visitors!

Save

Cite

Sponsored

PsychCase360: Choosing the Right Long-Acting Injectable for Patients With Schizophrenia

Explore two real-world schizophrenia cases with Roueen Rafeyan, MD and Melissa Vitale, PMHNP as they discuss challenges with medication adherence, transitioning to long-acting injectables (LAIs), and personalizing treatment strategies to improve patient outcomes.

Vol 27 • 2025 • Number 4

Read the Current Issue

Letter to the Editor

Knowledge of ECT for Catatonia

Original Research

Predictors of Depression Response in a Community ECT Clinic

Original Research

Medical Student Reactions to Interviewing Psychiatric Inpatients

Review Article

Climate Change and Mental Health

Rounds in the General Hospital

Management of Functional Neurological Disorder

Rounds in the General Hospital

PTSD Management in Primary Care

View current Issue

Related Articles

Daridorexant: Caution Is Needed About Suicidal Risk in Depressed Patients With Insomnia—Reply to Palagini et al

Letter to the Editor

Daridorexant: Caution Is Needed About Suicidal Risk in Depressed Patients With Insomnia—Reply to Palagini et al

July 3, 2023

Bénédicte Nobile, PharmD, PhD, and Philippe Courtet, MD, PhD, continue the discussion of potentially increased suicidal risk with daridorexant, a new hypnotic.

Bénédicte Nobile, Philippe Courtet

Aggravation of Suicide Risk With Daridorexant: Currently Not Enough Data to Show a Link

Letter to the Editor

Aggravation of Suicide Risk With Daridorexant: Currently Not Enough Data to Show a Link

July 3, 2023

Palagini and colleagues comment on a recent letter that suggested a role for daridorexant, a new hypnotic, in increasing suicide risk.

Laura Palagini, Pierre A. Geoffroy, Jean Arthur Micoulaud-Franchi, et al

Possible Suicidal Risk With Daridorexant

Letter to the Editor

Possible Suicidal Risk With Daridorexant

December 7, 2022

Instructions for use of the new anti-insomnia medication daridorexant mention cautious use in patients with history of suicidal behavior. This letter explores the factors that underlie this recommendation for...

Bénédicte Nobile, Emilie Olié, Philippe Courtet